Alejandro Martı́n

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial”.

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02321

N/A

1.9DataRank · unranked

62 citations

Fátima De la Cruz, Ana Jiménez Ubieto, Javier López‐Jiménez, Alejandro Martı́n, María José Terol +18 more

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

Cells(2023)10.3390/cells12151956

N/A

0DataRank · unranked

4 citations

Roberto Corchado‐Cobos, Adrián Blanco‐Gómez, Natalia García‐Sancha, Sonia Castillo‐Lluva, Ana Martín‐Garcia +47 more